Viewing Study NCT03630120


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-27 @ 11:20 AM
Study NCT ID: NCT03630120
Status: TERMINATED
Last Update Posted: 2021-07-14
First Post: 2018-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MCC-19442
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators